FDA DEVICE FACTS
Corin BiPolar-i
Corin U.S.A. Limited
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The BiPolar-i is intended for use in partial hip replacement (h emiarthroplasty) to provide increased patient mobility and reduce pain by replacing the natural femoral head and to restore hip joint articulation in patients where there is evidence of a satisfactory natural acet abulum and sufficient femoral bone to seat and support the femoral stem.
The BiPolar-i is intended for use in the following indications: x Non-inflammatory degenerative joint disease including osteoarth ritis and avascular necrosis in which the acetabulum does not require replacement, x Treatment of non-union, femoral neck and trochanteric fractures of the proximal femur x Revision of failed partial hip replacements in which the acetabulum does not require replacement The BiPolar-i is indicated for cementless use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。